Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients
Mercuro NJ, Gill CM, Kenney RM, Alangaden GJ, and Davis SL. Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients. Transpl Infect Dis 2020.
Transplant infectious disease
The Centers for Disease Control and Prevention estimates that resistant enterococci are responsible for 20,000 infections and over 1,000 deaths in the United States each year, representing 8% of nosocomial bloodstream infections.(1,2) Solid organ transplant (SOT) recipients, particularly liver, are among the populations at greatest risk of disease caused by resistant enterococci.(3,4) Colonization with vancomycin resistant-Enterococcus (VRE) is present in about 15% of patients with of abdominal transplant recipients, or on waiting lists.
ePub ahead of print